These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31781080)

  • 41. Antimicrobial resistance in
    Liu C; Wang Y; Azizian K; Omidi N; Hassan Kaviar V; Kouhsari E; Maleki A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1217-1231. PubMed ID: 35790112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and molecular characterization of Vibrio cholerae O1, non-O1 and non-O139 in tropical seafood in Cochin, India.
    Kumar R; Lalitha KV
    Foodborne Pathog Dis; 2013 Mar; 10(3):278-83. PubMed ID: 23489050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms of virstatin resistance by non-O1/non-O139 strains of Vibrio cholerae.
    Shakhnovich EA; Sturtevant D; Mekalanos JJ
    Mol Microbiol; 2007 Dec; 66(6):1331-41. PubMed ID: 17986190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics of non-O1/non-O139 Vibrio cholerae isolates and polymerase chain reaction analysis of their virulence factors.
    Lee YL; Hung PP; Tsai CA; Lin YH; Liu CE; Shi ZY
    J Microbiol Immunol Infect; 2007 Dec; 40(6):474-80. PubMed ID: 18087626
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Scanning the landscape of genome architecture of non-O1 and non-O139 Vibrio cholerae by whole genome mapping reveals extensive population genetic diversity.
    Chapman C; Henry M; Bishop-Lilly KA; Awosika J; Briska A; Ptashkin RN; Wagner T; Rajanna C; Tsang H; Johnson SL; Mokashi VP; Chain PS; Sozhamannan S
    PLoS One; 2015; 10(3):e0120311. PubMed ID: 25794000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phenotypic and molecular typing of Vibrio cholerae O1 and O139 isolates from India.
    Bhowmick TS; Das M; Roy N; Sarkar BL
    J Infect; 2007 May; 54(5):475-82. PubMed ID: 17087996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative genomic analysis of two isolates of Vibrio cholerae O1 Ogawa El Tor isolated during outbreak in Mariupol in 2011.
    Kuleshov KV; Kostikova A; Pisarenko SV; Kovalev DA; Tikhonov SN; Savelievа IV; Saveliev VN; Vasilieva OV; Zinich LS; Pidchenko NN; Kulichenko AN; Shipulin GA
    Infect Genet Evol; 2016 Oct; 44():471-478. PubMed ID: 27480918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and phenotypic analysis of Vibrio cholerae non-O1, non-O139 isolated from German and Austrian patients.
    Schirmeister F; Dieckmann R; Bechlars S; Bier N; Faruque SM; Strauch E
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):767-78. PubMed ID: 24213848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic and functional insights into antibiotic resistance genes
    Saha M; Pragasam AK; Kumari S; Verma J; Das B; Bhadra RK
    Microbiology (Reading); 2024 Jan; 170(1):. PubMed ID: 38180462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance and Genomics of Toxigenic
    Hounmanou YMG; Leekitcharoenphon P; Hendriksen RS; Dougnon TV; Mdegela RH; Olsen JE; Dalsgaard A
    Front Microbiol; 2019; 10():901. PubMed ID: 31114556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Difference of Phenotype and Genotype Between Human and Environmental: Isolated
    Osawa K; Shigemura K; Kitagawa K; Kuntaman K; Mertaniasih NM; Setyarini W; Arizandy D; Rahadjo D; Osawa R; Shirakawa T; Fujisawa M
    Indian J Microbiol; 2020 Jun; 60(2):230-238. PubMed ID: 32255856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal shifts in traits of Vibrio cholerae strains isolated from hospitalized patients in Calcutta: a 3-year (1993 to 1995) analysis.
    Mukhopadhyay AK; Garg S; Mitra R; Basu A; Rajendran K; Dutta D; Bhattacharya SK; Shimada T; Takeda T; Takeda Y; Nair GB
    J Clin Microbiol; 1996 Oct; 34(10):2537-43. PubMed ID: 8880516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Environmental Surveillance of
    Bwire G; Debes AK; Orach CG; Kagirita A; Ram M; Komakech H; Voeglein JB; Buyinza AW; Obala T; Brooks WA; Sack DA
    Front Microbiol; 2018; 9():1560. PubMed ID: 30123189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular analysis on non-O1 and non-O139 Vibrio cholerae isolates].
    Chen DL; Zhang P; Wang DC; Chen J; Yu BQ; Cheng XF; Diao BW; Zhou HJ; Zhu M; Hu WF; Zhan SW; Jing HQ; Kan B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Dec; 33(12):1265-8. PubMed ID: 23336198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of the properties of Vibrio cholerae O139, O1 and other non-O1 strains.
    Nandy RK; Sengupta TK; Mukhopadhyay S; Ghose AC
    J Med Microbiol; 1995 Apr; 42(4):251-7. PubMed ID: 7707332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholera in a developing megacity; Karachi, Pakistan.
    Sheikh A; Khan A; Malik T; Fisher-Hoch SP
    Epidemiol Infect; 1997 Dec; 119(3):287-92. PubMed ID: 9440430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virulence-associated genes and molecular characteristics of non-O1/non-O139 Vibrio cholerae isolated from hepatitis B cirrhosis patients in China.
    Jiang F; Bi R; Deng L; Kang H; Gu B; Ma P
    Int J Infect Dis; 2018 Sep; 74():117-122. PubMed ID: 29969728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxigenic Vibrio cholerae identified in estuaries of Tanzania using PCR techniques.
    Dalusi L; Lyimo TJ; Lugomela C; Hosea KM; Sjöling S
    FEMS Microbiol Lett; 2015 Mar; 362(5):. PubMed ID: 25743072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
    Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
    J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vibrio cholerae-An emerging pathogen in Austrian bathing waters?
    Rehm C; Kolm C; Pleininger S; Heger F; Indra A; Reischer GH; Farnleitner AAH; Kirschner AKT
    Wien Klin Wochenschr; 2023 Nov; 135(21-22):597-608. PubMed ID: 37530997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.